These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21807788)

  • 1. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
    Kirwan JR; Tugwell PS
    J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient perspective: choosing or developing instruments.
    Kirwan JR; Fries JF; Hewlett S; Osborne RH
    J Rheumatol; 2011 Aug; 38(8):1716-9. PubMed ID: 21807791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.
    Kirwan JR; Fries JF; Hewlett SE; Osborne RH; Newman S; Ciciriello S; van de Laar MA; Dures E; Minnock P; Heiberg T; Sanderson TC; Flurey CA; Leong AL; Montie P; Richards P
    J Rheumatol; 2011 Aug; 38(8):1711-5. PubMed ID: 21807790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domains selection for patient-reported outcomes: current activities and options for future methods.
    Tugwell PS; Petersson IF; Boers M; Gossec L; Kirwan JR; Rader T; Sanderson TC; van de Laar MA; Ueffing E; Witter JP
    J Rheumatol; 2011 Aug; 38(8):1702-10. PubMed ID: 21807789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.
    Kirwan JR; Minnock P; Adebajo A; Bresnihan B; Choy E; de Wit M; Hazes M; Richards P; Saag K; Suarez-Almazor M; Wells G; Hewlett S
    J Rheumatol; 2007 May; 34(5):1174-7. PubMed ID: 17477482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
    Petkovic J; Barton JL; Flurey C; Goel N; Bartels CM; Barnabe C; de Wit MPT; Lyddiatt A; Lacaille D; Welch V; Boonen A; Shea B; Christensen R; Maxwell LJ; Campbell W; Jull J; Toupin-April K; Singh JA; Goldsmith CH; Sreih AG; Pohl C; Hofstetter C; Beaton DE; Buchbinder R; Guillemin F; Tugwell PS
    J Rheumatol; 2017 Nov; 44(11):1727-1733. PubMed ID: 28202740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis.
    Kirwan JR; Hewlett S
    J Rheumatol; 2007 May; 34(5):1171-3. PubMed ID: 17477481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perspective on remission in rheumatoid arthritis.
    van Tuyl LH; Smolen JS; Wells GA; Scholte-Voshaar M; Hoogland W; Boers M
    J Rheumatol; 2011 Aug; 38(8):1735-8. PubMed ID: 21807794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.
    Kirwan JR; Boonen A; Harrison MJ; Hewlett SE; Wells GA; Singh JA; Furst DE; Dworkin RH
    J Rheumatol; 2011 Aug; 38(8):1728-34. PubMed ID: 21807793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.
    Strand V; Boers M; Idzerda L; Kirwan JR; Kvien TK; Tugwell PS; Dougados M
    J Rheumatol; 2011 Aug; 38(8):1720-7. PubMed ID: 21807792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
    Beaton DE; Dyer S; Boonen A; Verstappen SM; Escorpizo R; Lacaille DV; Bosworth A; Gignac MA; Leong A; Purcaru O; Leggett S; Hofstetter C; Peterson IF; Tang K; Fautrel B; Bombardier C; Tugwell PS
    J Rheumatol; 2016 Jan; 43(1):214-22. PubMed ID: 26329339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
    Kirwan JR; Ahlmén M; de Wit M; Heiberg T; Hehir M; Hewlett S; Katz PP; Minnock P; Quest EM; Richards P
    J Rheumatol; 2005 Nov; 32(11):2246-9. PubMed ID: 16265711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.
    van Tuyl LH; Sadlonova M; Davis B; Flurey C; Goel N; Hewlett SE; Hill CL; Hoogland W; Kirwan JR; van Schaardenburg D; Scholte-Voshaar M; Smolen JS; Stamm T; Wells GA; Boers M
    J Rheumatol; 2016 Jan; 43(1):203-7. PubMed ID: 25684772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.
    Kirwan JR; Hewlett SE; Heiberg T; Hughes RA; Carr M; Hehir M; Kvien TK; Minnock P; Newman SP; Quest EM; Taal E; Wale J
    J Rheumatol; 2005 Nov; 32(11):2250-6. PubMed ID: 16265712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
    Tang K; Boonen A; Verstappen SM; Escorpizo R; Luime JJ; Lacaille D; Fautrel B; Bosworth A; Cifaldi M; Gignac MA; Hofstetter C; Leong A; Montie P; Petersson IF; Purcaru O; Bombardier C; Tugwell PS; Beaton DE
    J Rheumatol; 2014 Jan; 41(1):165-76. PubMed ID: 24128774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.